Applied Genetic Technologies's

• AGTC's Stock Performance relative to its Competitors

Bluebird Bio Inc Share Performance +22.72% 30 Days

Bluebird Bio Inc Profile Bluebird Bio Inc's business model focuses on developing gene therapies for severe genetic diseases and cancer. They collaborate with academic and industry partners to leverage their gene editing and cell-based technologies for discovering potential treatments and advancing these therapies through clinical trials. More about Bluebird Bio Inc 's Market Share

Orchard Therapeutics Plc Share Performance +4.44% This Quarter

Orchard Therapeutics Plc Profile Orchard Therapeutics Plc operates as a biotechnology company specializing in gene therapies for rare diseases. Their business model involves developing and commercializing potentially curative gene therapies to address the underlying cause of these diseases. They collaborate with academic and industry partners to advance their research and utilize their expertise to bring innovative therapies to patients in need. More about Orchard Therapeutics Plc's Market Share

Protalix Biotherapeutics inc Share Performance +36.11% This Quarter

Protalix Biotherapeutics inc Profile Protalix Biotherapeutics Inc. operates under a business model focused on the development, production, and commercialization of recombinant therapeutic proteins using plant cell culture technology, aiming to address unmet medical needs and provide innovative treatment options to patients worldwide. More about Protalix Biotherapeutics inc 's Market Share

Prokidney Corp Share Performance -14.57% This Year

Prokidney Corp Profile Prokidney Corp is a medical device company that specializes in developing innovative solutions for kidney dialysis treatment. Their business model focuses on designing, manufacturing, and marketing advanced dialysis machines and related consumables to healthcare providers worldwide. Through strategic partnerships and collaborations, Prokidney Corp aims to improve patient outcomes and enhance the overall efficiency of kidney dialysis procedures. More about Prokidney Corp 's Market Share

Sources: Applied Genetic Technologies Corporation’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Saturday, September 12, 2026 6:22 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Applied Genetic Technologies Corporation versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.